Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pediatrics ; 119(1): e1-5, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17200234

RESUMO

Young children exposed to tuberculosis have a high risk of progression to severe tuberculosis disease, but diagnosis of recent infection is hindered by the poor sensitivity of the tuberculin skin test. Whether new blood tests can detect latent infection in this vulnerable group is unknown because there is no gold standard. We monitored a tuberculin skin test-negative infant whose mother had infectious multidrug-resistant tuberculosis with enzyme-linked immunospot, a blood test that enumerates Mycobacterium tuberculosis-specific T cells. The enzyme-linked immunospot test became persistently positive by 6 months, and 18 months later the child developed active tuberculosis despite appropriate chemoprophylaxis. At this point, the magnitude of the enzyme-linked immunospot response increased >10-fold. Our findings demonstrate that this blood test detected latent infection with dormant, yet viable, bacilli and illustrate how enzyme-linked immunospot could improve diagnosis of childhood tuberculosis infection.


Assuntos
Antígenos de Bactérias/imunologia , Ensaio de Imunoadsorção Enzimática , Interferon gama/biossíntese , Mycobacterium tuberculosis/imunologia , Linfócitos T/imunologia , Tuberculose Resistente a Múltiplos Medicamentos/congênito , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Antituberculosos/uso terapêutico , Quimioprevenção , Impressões Digitais de DNA , Feminino , Humanos , Lactente , Recém-Nascido , Mycobacterium tuberculosis/classificação , Polimorfismo de Fragmento de Restrição , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Teste Tuberculínico , Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle
2.
Am J Respir Crit Care Med ; 170(3): 288-95, 2004 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-15130907

RESUMO

Molecular epidemiology indicates significant transmission of Mycobacterium tuberculosis after casual contact with infectious tuberculosis cases. We investigated M. tuberculosis transmission after brief exposure using a T cell-based assay, the enzyme-linked-immunospot (ELISPOT) for IFN-gamma. After childbirth, a mother was diagnosed with sputum smear-positive multidrug-resistant tuberculosis. Forty-one neonates and 47 adults were present during her admission on the maternity unit; 11 weeks later, all underwent tuberculin skin testing (TST) and ELISPOT. We correlated test results with markers of exposure to the index case. The participants, who were asymptomatic and predominantly had no prior tuberculosis exposure, had 6.05 hours mean exposure (range: 0-65 hours) to the index case. Seventeen individuals, including two newborns, were ELISPOT-positive, and ELISPOT results correlated significantly with three of four predefined measures of tuberculosis exposure. For each hour sharing room air with the index case, the odds of a positive ELISPOT result increased by 1.05 (95% CI: 1.02-1.09, p = 0.003). Only four adults were TST-positive and TST results did not correlate with exposure. Thus, ELISPOT, but not TST, suggested quite extensive nosocomial transmission of multidrug-resistant M. tuberculosis after brief exposure. These results help to explain the apparent importance of casual contact for tuberculosis transmission, and may have implications for prevention.


Assuntos
Infecção Hospitalar/diagnóstico , Infecção Hospitalar/transmissão , Transmissão de Doença Infecciosa/classificação , Resistência a Múltiplos Medicamentos/imunologia , Linfócitos T/imunologia , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Tuberculose Resistente a Múltiplos Medicamentos/transmissão , Adulto , Vacina BCG/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/imunologia , Infecção Hospitalar/microbiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Hipersensibilidade Tardia/complicações , Hipersensibilidade Tardia/imunologia , Recém-Nascido , Interferon gama , Masculino , Mycobacterium tuberculosis , Razão de Chances , Sensibilidade e Especificidade , Fatores de Tempo , Teste Tuberculínico , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/imunologia , Tuberculose Resistente a Múltiplos Medicamentos/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA